Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.
Quick Stats
Jan 30, 202654.8
AI Score
HOLD0.98
Volume Ratio
Mar 10, 2026
Next Earnings
15
+ve Days (30d)
15
-ve Days (30d)
RAPP Stock Summary
Last updated Jan 30, 2026
RAPP is currently trading at $26.61, positioned above its 200-day moving average of $20.12, indicating a long-term uptrend. The stock has a 52-week range of $6.43 to $42.269.
Technical Analysis: The 50-day moving average stands at $28.42, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 44.944, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.01, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates RAPP at 54.8/100 with a HOLD recommendation.
RAPP (Rapport Therapeutics, Inc. Common Stock) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 44.944 |
| CMF (20) | -0.01 |
| ROC (10) | -0.931 |
| ADX (14) | 12.352 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.568 |
| AROONOSC (14) | -100.0 |
| WILLAMS %R (14) | -64.946 |
| MFI (14) | 46.563 |
RAPP Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
RAPP Price vs Max Options Open Interest
RAPP Max Change In Options Open Interest
RAPP Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
RAPP Daily Out of Money Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
RAPP Daily In the Money Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
RAPP Most Active Options by Volume(near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Rapport Therapeutics, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
RAPP Moving Averages Analysis
Rapport Therapeutics, Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jan 30, 2026
RAPP (Rapport Therapeutics, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 26.76 |
| 20 | 27.33 |
| 30 | 28.36 |
| 50 | 28.42 |
| 100 | 27.35 |
| 200 | 20.12 |
RAPP Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 1.3 billion |
| Earnings/Share ($) | -2.27 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -2.8283 |
| EPS Estimate Next Year ($) | -3.4267 |
| WallStreet Target Price ($) | 52.25 |
| Most Recent Quarter |